Friday 6 November 2026 Export KRYS’s income statement to Excel — free account

Krystal Biotech, Inc.

Krystal Biotech, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $389.1 million, up 33.9% from fiscal 2024.

Revenue: +30.2%
EPS: −22.3%
Free cash flow: +137.8%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

300.31 0.06 +0.02%

Follow KRYS

Alert me

Market cap: $8.9B
P/E: 39.2×
Fwd P/E: 45.7×
Dividend yield: —
F-score: 7/9
Altman Z: 39.03
Beneish M: −2.27
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	34.82	33.33	44.94	43.42
P/S ratio Full definition →		18.34	18.13	24.92	20.95
P/FCF ratio Full definition →		37.69	31.87	42.57	31.76
P/Operating CF Full definition →		92.07	94.12	146.75	107.91
P/B ratio Full definition →		5.85	5.93	8.08	6.86
Price to Tangible BV Full definition →		5.85	5.93	8.08	6.86
EV/Sales Full definition →		16.21	16.16	23.00	19.01
EV/EBITDA Full definition →		37.58	36.37	49.55	38.14
EV/Operating CF Full definition →		31.40	26.94	37.19	27.58
EV/FCF Full definition →		33.31	28.40	39.29	28.82
Quick Ratio Full definition →		9.28	8.82	7.73	7.35
Current Ratio Full definition →		9.95	9.46	8.32	7.89
Net Debt/EBITDA Full definition →		(17.98)	(14.86)	(14.10)	(12.52)
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.33	0.34	0.33	0.33
Operating CF/Net income Full definition →		1.51	1.44	1.37	1.45
Capex/Depreciation Full definition →		(1.21)	(4.14)	(2.28)	(0.59)
Research and Development Expense of Revenue Full definition →		13.81%	13.18%	12.18%	11.69%
Selling, General and Administrative Expense of Revenue Full definition →		38.70%	35.25%	33.43%	26.50%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		12.85%	11.70%	11.87%	10.95%
Graham Net Nets Full definition →		0.13	0.12	0.08	0.10
Graham Number Full definition →		81.93	87.19	92.54	91.41
Earnings Yield Full definition →		2.87%	3.00%	2.23%	2.30%
Free Cash Flow Yield Full definition →		2.65%	3.14%	2.35%	3.15%
Revenue per Share Full definition →		3.70	3.97	4.04	4.30
Operating CF per Share Full definition →		2.68	2.74	2.53	3.08
Capex per Share Full definition →		(0.07)	(0.24)	(0.12)	(0.03)
Free Cash Flow per Share Full definition →		2.60	2.50	2.41	3.05
Cash per Share Full definition →		28.60	28.11	28.64	30.80
Shareholders Equity per Share Full definition →		42.14	43.59	46.03	48.48
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		42.14	43.59	46.03	48.48
Free Cash Flow Full definition →		75.37	73.23	71.22	90.25
Working Capital Full definition →		921.66	911.94	932.25	979.62
Capital Expenditures Full definition →		(2.14)	(7.15)	(3.56)	(1.00)
Net Current Asset Value Full definition →		910.37	899.50	918.13	971.29
EV/EBIT Full definition →		39.11	37.72	51.22	39.27
Capex to Sales Full definition →		0.02	0.06	0.03	0.01
Price to Operating Income Full definition →		44.24	42.33	55.50	43.28
Other line items
Average Receivables Full definition →		116.09	115.14	125.05	131.37
Average Payables Full definition →		4.11	3.38	6.83	4.41
Average Inventory Full definition →		33.49	36.29	38.30	44.21
Average Assets Full definition →		1,194.82	1,235.69	1,319.52	1,413.08
Average Common Equity Full definition →		1,082.97	1,130.70	1,199.89	1,286.73

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly